Lecanemab: Experts criticise European Commission approval of Alzheimer's drug. Iacobucci G. BMJ 2025;389:r796.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iacobucci G. Lecanemab: Experts criticise European Commission approval of Alzheimer's drug. BMJ 2025;389:r796.
PMID: 40262818